
Need Support?

Arkansas HB 1297 never became law. It was withdrawn in April 2025, but its ripple effects are still being felt in lab billing circles today. The bill would have barred insurers from using AI as the sole reason for denying, delaying, or downgrading claims, and it would have given the state insurance commissioner real enforcement power. Without it, commercial payers in Arkansas aren’t bound by any state-level AI transparency rule for private claims.
That said, Arkansas did pass Act 848, which requires human oversight for AI decisions made by public entities, including state Medicaid operations. So while private insurers remain unregulated on this front, Medicaid claims have some protection.
Meanwhile, other states like Iowa, Washington, and Alabama have already enacted their own AI prior authorization laws. If your lab bills patients outside Arkansas, those rules still apply to those claims. The smartest move right now? Strengthen documentation, track denial patterns closely, and treat every appeal like the algorithm behind it needs to be proven wrong.
Quick question for you: if an insurer’s algorithm denies your lab’s claim in just three seconds flat, who’s actually accountable for that call? Right now, in most states, the honest answer is “nobody in particular.” That’s the exact problem Arkansas lawmakers tried to fix in 2025, and even though their bill never made it into law, its effects are all over the billing landscape labs are dealing with in 2026.
If you run a lab, manage pathology billing, or handle revenue cycle work for a diagnostics company, this one’s for you. We’re breaking down what Arkansas HB 1297 proposed, why it got pulled, and what it means for your claims, your appeals, and laboratory billing services in Arkansas going forward.
Arkansas House Bill 1297, filed by Representative Lee Johnson and Senator Missy Irvin, landed in the state legislature on January 29, 2025, as a bill concerning artificial intelligence, algorithms, and other automated technologies, aimed at regulating certain practices of healthcare payers. It moved through committee, picked up an amendment in late February, and then just stopped. The House withdrew it on April 1, 2025.
So no, HB 1297 isn’t a law you can cite in an appeal letter today. But that doesn’t mean it doesn’t matter at all. Think of it like a trial. It presented an idea, showed lawmakers (and the insurance industry) what real AI oversight could look like, and set the tone for a wave of similar bills that have since passed in other states.
| Proposed Requirement | What It Meant for Payers | Why Labs Cared |
|---|---|---|
| No AI-only denials | A human had to sign off before a claim could be denied, delayed, or downgraded | Fewer bulk denials on molecular and toxicology panels |
| Algorithm disclosure | Insurers had to reveal how their AI models worked and their known limits | Labs could actually see the logic behind a denial, not just get a form letter |
| Commissioner oversight | Audits and fines up to $25,000 per violation | Real financial consequences for careless AI use |
Arkansas did pass an AI oversight law in 2025, but it’s not a healthcare insurance law. House Bill 1958, signed by Governor Sarah Huckabee Sanders on April 17, 2025, became Act 848. It applies to public entities, meaning state agencies, public schools, and local governments, not private insurance carriers. The law requires those public entities to create formal policies governing AI and automated decision tools, with a human reviewer always making the final call.
That’s an important distinction. Act 848 won’t stop a commercial payer or a Medicaid managed care organization from leaning on AI to review your lab claims. It’s a government-operations law, not a private insurance law. If your lab bills Arkansas Medicaid directly, though, the human-oversight principle behind Act 848 is worth knowing, since state Medicaid operations do fall under its umbrella.
This law passed with huge support in the Arkansas legislature. It’s a sign that lawmakers agree AI shouldn’t make final calls without a human checking its work.
Let’s look at it at a glance:
Here’s an interesting fact. Something that Arkansas started and didn’t finish, other states are running with. As of early 2026, more than 25 states had issued guidance based on the National Association of Insurance Commissioners’ 2023 model bulletin, which sets expectations that AI-assisted insurance decisions still comply with existing anti-discrimination and unfair-practice laws.
A handful of states have gone further and passed hard prior authorization rules that lab billing teams everywhere should watch:
| State | Law | Key Rule |
|---|---|---|
| Iowa | HF 2635 | AI can't be the sole basis for a denial, delay, or downgrade of a medical necessity request; a qualified reviewer or clinical peer must sign off |
| Washington | SB 5395 | Only a licensed physician or health professional can deny a prior authorization based on medical necessity |
| Alabama | SB 63 | AI-driven prior authorization decisions must rely on the patient's own medical history, not group datasets |
| Indiana | HB 1271 | Bans AI as the sole basis for downcoding a claim without a clinician reviewing the record |
| Utah | SB 319 | Insurers must publicly disclose whether AI is used to review prior authorization requests, effective January 1, 2027 |
Whether or not a state has a hard AI law on the books, one thing hasn’t changed: bulk denials on high-volume and low-margin lab tests are a real drain on cash flow. Molecular diagnostics, toxicology screens, and genetic panels get caught a lot in algorithmic dragnet more than routine chemistry panels do, simply because they’re higher-cost and easier for an algorithm to flag.
This becomes easier when you use denial management services to track denial reasons and patterns and make it a proactive, rather than reactive, process for future claims.
All of the above actions are important for laboratories across Arkansas to get paid fully and protect their revenue. But when you’re busy performing tests and managing other aspects of your day-to-day lab operations, doing that all isn’t an easy task.
Solution? Partner with a dedicated Arkansas billing company, like TransLabs, that provides comprehensive laboratory RCM solutions, helping manage all these RCM aspects. The best part is you don’t need to hire billers for the task. They have a dedicated staff of billing experts who are well-versed in all the ins and outs of the billing landscape across The Wonder State.
They help with payer compliance and make sure to review AI-automated claim denials, fight them through well-documented appeals, and get your laboratory paid every dollar you deserve.